贝斯特(300580) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was CNY 349,592,095.51, representing a 1.89% increase compared to CNY 343,114,436.07 in the same period last year[4] - Net profit attributable to shareholders was CNY 69,398,611.60, a slight increase of 0.23% from CNY 69,241,291.66 year-on-year[4] - The company experienced a 371.97% increase in investment income, reaching CNY 7,393,731.93 compared to a loss of CNY -2,718,633.40 in the previous year[11] - Net profit for the current period was ¥69,400,095.98, slightly down from ¥69,440,180.62 in the previous period, reflecting a decrease of 0.06%[22] - The company’s total comprehensive income for the current period was ¥69,519,698.74, slightly up from ¥69,440,180.62 in the previous period[22] Cash Flow - Operating cash flow net amount increased by 13.08% to CNY 54,690,919.03 from CNY 48,365,790.79 in the previous year[4] - Cash flow from operating activities generated a net amount of ¥54,690,919.03, up from ¥48,365,790.79 in the previous period, indicating a growth of 6.8%[24] - The company reported a significant cash outflow related to investment activities, which may impact future liquidity[25] - Net cash flow from investment activities was -86,315,219.63, compared to -65,563,676.08 in the previous period[25] - The net increase in cash and cash equivalents was -31,638,836.66, compared to -17,141,734.17 in the previous period[25] Assets and Liabilities - Total assets at the end of Q1 2025 were CNY 3,735,995,543.02, a 0.13% increase from CNY 3,731,065,443.12 at the end of the previous year[5] - The total liabilities decreased to CNY 560,848,974.94 from CNY 626,755,603.68, indicating a reduction of about 10.5%[18] - The total current liabilities decreased to CNY 345,194,603.27 from CNY 406,478,214.54, indicating a reduction of about 15.0%[18] - The company's cash and cash equivalents decreased to CNY 154,680,067.27 from CNY 186,286,103.48, reflecting a decline of approximately 16.4%[17] - The company's accounts receivable decreased to CNY 465,524,817.07 from CNY 487,097,309.16, a decline of approximately 4.4%[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 45,602, with the largest shareholder holding 49.67% of the shares[13] - The equity attributable to shareholders increased by 2.29% to CNY 3,164,891,244.24 from CNY 3,094,055,999.98 at the end of the last year[5] - The company's total equity remained stable at CNY 3,175,146,568.08, unchanged from the previous period[18] Research and Development - Research and development expenses rose significantly by 46.27% to CNY 18,119,917.78, up from CNY 12,387,652.23 in Q1 2024[11] - Research and development expenses rose significantly to ¥18,119,917.78, an increase of 46.5% compared to ¥12,387,652.23 in the previous period[21] Corporate Governance and Reporting - The first quarter report was not audited, indicating potential implications for financial reliability[26] - The company plans to implement new accounting standards starting in 2025, which may affect financial reporting[26] - The cash flow from financing activities was not detailed, indicating a need for further clarification in future reports[25] - The board meeting was held on April 21, 2025, indicating ongoing corporate governance activities[27]